|
1
|
Whiting DR, Guariguata L, Weil C and Shaw
J: IDF diabetes atlas: Global estimates of the prevalence of
diabetes for 2011 and 2030. Diabetes Res Clin Pract. 94:311–321.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thrainsdottir IS, Aspelund T, Thorgeirsson
G, Gudnason V, Hardarson T, Malmberg K, Sigurdsson G and Rydén L:
The association between glucose abnormalities and heart failure in
the population-based Reykjavik study. Diabetes Care. 28:612–616.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Redfield MM, Jacobsen SJ, Burnett JC Jr,
Mahoney DW, Bailey KR and Rodeheffer RJ: Burden of systolic and
diastolic ventricular dysfunction in the community: Appreciating
the scope of the heart failure epidemic. JAMA. 289:194–202. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marcinkiewicz A, Ostrowski S and Drzewoski
J: Can the onset of heart failure be delayed by treating diabetic
cardiomyopathy? Diabetol Metab Syndr. 9:212017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang X, Pan L, Yang K, Fu Y, Liu Y, Chi
J, Zhang X, Hong S, Ma X and Yin X: H3 relaxin protects against
myocardial injury in experimental diabetic cardiomyopathy by
inhibiting myocardial apoptosis, fibrosis and inflammation. Cell
Physiol Biochem. 43:1311–1324. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abdel-Hamid AA and Firgany Ael-D:
Atorvastatin alleviates experimental diabetic cardiomyopathy by
suppressing apoptosis and oxidative stress. J Mol Histol.
46:337–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niu J, Gilliland MG, Jin Z, Kolattukudy PE
and Hoffman WH: MCP-1and IL-1β expression in the myocardia of two
young patients with Type 1 diabetes mellitus and fatal diabetic
keto-acidosis. Exp Mol Pathol. 96:71–79. 2014. View Article : Google Scholar
|
|
8
|
Liu Z, Zhao N, Zhu H, Zhu S, Pan S, Xu J,
Zhang X, Zhang Y and Wang J: Circulating interleukin-1β promotes
endoplasmic reticulum stress-induced myocytes apoptosis in diabetic
cardiomyopathy via interleukin-1 receptor-associated kinase-2.
Cardiovasc Diabetol. 14:1252015. View Article : Google Scholar
|
|
9
|
Westermann D, Rutschow S, Jäger S,
Linderer A, Anker S, Riad A, Unger T, Schultheiss HP, Pauschinger M
and Tschöpe C: Contributions of inflammation and cardiac matrix
metalloproteinase activity to cardiac failure in diabetic
cardiomyopathy: The role of angiotensin type 1 receptor antagonism.
Diabetes. 56:641–646. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Fu Y, Li H, Shen L, Chang Q, Pan
L, Hong S and Yin X: H3 relaxin inhibits the collagen synthesis via
ROS and P2X7R-mediated NLRP3 inflammasome activation in cardiac
fibroblasts under high glucose. J Cell Mol Med. 22:1816–1825. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ and
Jo EK: Upregulated NLRP3 inflammasome activation in patients with
type 2 diabetes. Diabetes. 62:194–204. 2013. View Article : Google Scholar
|
|
12
|
Wang C, Pan Y, Zhang QY, Wang FM and Kong
LD: Quercetin and allopurinol ameliorate kidney injury in
STZ-treated rats with regulation of renal NLRP3 inflammasome
activation and lipid accumulation. PLoS One. 7:e382852012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lebreton F, Berishvili E, Parnaud G,
Rouget C, Bosco D, Berney T and Lavallard V: NLRP3 inflammasome is
expressed and regulated in human islets. Cell Death Dis. 9:7262018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo B, Huang F, Liu Y, Liang Y, Wei Z, Ke
H, Zeng Z, Huang W and He Y: NLRP3 inflammasome as a molecular
marker in diabetic cardiomyopathy. Front Physiol. 8:5192017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Geahlen RL: Getting Syk: Spleen tyrosine
kinase as a therapeutic target. Trends Pharmacol Sci. 35:414–422.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Javadov S, Jang S and Agostini B:
Crosstalk between mitogen-activated protein kinases and
mitochondria in cardiac diseases: Therapeutic perspectives.
Pharmacol Ther. 144:202–225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han MS, Jung DY, Morel C, Lakhani SA, Kim
JK, Flavell RA and Davis RJ: JNK expression by macrophages promotes
obesity- induced insulin resistance and inflammation. Science.
339:218–222. 2013. View Article : Google Scholar
|
|
18
|
Kuo WW, Wang WJ, Tsai CY, Way CL, Hsu HH
and Chen LM: Diallyl trisufide (DATS) suppresses high
glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFκB
signaling via attenuating ROS generation. Int J Cardiol.
168:270–280. 2013. View Article : Google Scholar
|
|
19
|
Watanabe N, Shikata K, Shikata Y, Sarai K,
Omori K, Kodera R, Sato C, Wada J and Makino H: Involvement of
MAPKs in ICAM-1 expression in glomerular endothelial cells in
diabetic nephropathy. Acta Med Okayama. 65:247–257. 2011.PubMed/NCBI
|
|
20
|
Yang WS, Chang JW, Han NJ, Lee SK and Park
SK: Spleen tyrosine kinase mediates high glucose-induced
transforming growth factor-β1 up-regulation in proximal tubular
epithelial cells. Exp Cell Res. 318:1867–1876. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pang A, Hu Y, Zhou P, Long G, Tian X, Men
L, Shen Y, Liu Y and Cui Y: Corin is down-regulated and exerts
cardioprotective action via activating pro-atrial natriuretic
peptide pathway in diabetic cardiomyopathy. Cardiovasc Diabetol.
14:1342015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Diamant M, Lamb HJ, Smit JW, de Roos A and
Heine RJ: Diabetic cardiomyopathy in uncomplicated type 2 diabetes
is associated with the metabolic syndrome and systemic
inflammation. Diabetologia. 48:1669–1670. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pan Y, Wang Y, Zhao Y, Peng K, Li W, Wang
Y, Zhang J, Zhou S, Liu Q, Li X, et al: Inhibition of JNK
phosphorylation by a novel curcumin analog prevents high
glucose-induced inflammation and apoptosis in cardiomyocytes and
the development of diabetic cardiomyopathy. Diabetes. 63:3497–3511.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun X, Hao H, Han Q, Song X, Liu J, Dong
L, Han W and Mu Y: Human umbilical cord-derived mesenchymal stem
cells ameliorate insulin resistance by suppressing NLRP3
inflammasome-mediated inflammation in type 2 diabetes rats. Stem
Cell Res Ther. 8:2412017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Youm YH, Adijiang A, Vandanmagsar B, Burk
D, Ravussin A and Dixit VD: Elimination of the NLRP3-ASC
inflammasome protects against chronic obesity-induced pancreatic
damage. Endocrinology. 152:4039–4045. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang C, Zou S, Cui Z, Guo P, Meng Q, Shi
X, Gao Y, Yang G and Han Z: Zerumbone protects INS-1 rat pancreatic
beta cells from high glucose-induced apoptosis through generation
of reactive oxygen species. Biochem Biophys Res Commun.
460:205–209. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen J, Mo H, Guo R, You Q, Huang R and Wu
K: Inhibition of the leptin-induced activation of the p38 MAPK
pathway contributes to the protective effects of naringin against
high glucose induced injury in H9c2 cardiac cells. Int J Mol Med.
33:605–612. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu Y, Jia XJ, Zhang WP, Fang TT, Hu J, Ma
SF and Gao Q: The protective effect of low-dose Ethanol on
myocardial fibrosis through downregulating the JNK signaling
pathway in diabetic rats. J Diabetes Res. 2016:38342832016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yan X, Xun M, Li J, Wu L, Dou X and Zheng
J: Activation of Na+/K+-ATPase attenuates
high glucose-induced H9c2 cell apoptosis via suppressing ROS
accumulation and MAPKs activities by DRm217. Acta Biochim Biophys
Sin (Shanghai). 48:883–893. 2016. View Article : Google Scholar
|
|
31
|
Zhou H, Yue Y, Wang J, Ma Q and Chen Y:
Melatonin therapy for diabetic cardiomyopathy: A mechanism
involving Syk-mitochondrial complex I-SERCA pathway. Cell Signal.
47:88–100. 2018.PubMed/NCBI
|
|
32
|
Chen YF, Long GF, Tian XX, Qiao YC, Li SY,
Xue MT, Liu YD, Cui YJ and Shen YN: Studies on the mechanism of Syk
and JNK in the heart tissue of type 1 diabetic rats. Tianjin Med J.
45:463–467. 2017.In Chinese.
|
|
33
|
Long G, Xue M, Cheb Y, Qiao Y, Tian X, Li
S, Liu Y, Shen Y and Cui Y: Effects of Syk on regulation of high
glucose-induced apoptosis of H9c2 myocardial cells and its
mechanism. Int J Endocrinol Metabolism. 37:303–307. 2017.
|
|
34
|
Shi J, Zhao Y, Wang K, Shi X, Wang Y,
Huang H, Zhuang Y, Cai T, Wang F and Shao F: Cleavage of GSDMD by
inflammatory caspases determines pyroptotic cell death. Nature.
526:660–665. 2015.PubMed/NCBI
|
|
35
|
Kovacs SB and Miao EA: Gasdermins:
Effectors of pyroptosis. Trends Cell Biol. 27:673–684.
2017.PubMed/NCBI
|
|
36
|
Liu Z, Gan L, Xu Y, Luo D, Ren Q, Wu S and
Sun C: Melatonin alleviates inflammasome-induced pyroptosis through
inhibiting NF-κB/GSDMD signal in mice adipose tissue. J Pineal Res.
63:2017.
|
